Occident Group AG

https://www.occident.group

LinkedIn: https://linkedin.com/company/occidentgroup

OCCIDENT is an international venture capital investor with offices in Munich and Zug, is owner-managed and invests own wealth. Its aim is to make a positive contribution to society through sustainable and meaningful investments. OCCIDENT invests in innovative deep tech start-ups with excellent technologies in the fields of life sciences, high-tech and digital with broad application possibilities and the potential for further value-generating developments. The geographic focus is Germany and Switzerland. The preferred stage for initial financing is from seed rounds or later and from 0.5 million euros. OCCIDENT distinguishes itself in particular by its in-depth knowledge of the technology and the versatile support offered to its portfolio companies by its competent team of experts. *

	Start	1993-01-01 established
	Group	Occident (Group)
	Industry	finance
	Industry 2	private equity

	Region	Zug ZG
	Country	Switzerland
	Street	10 Bahnhofstr.
	City	6300 Zug ZG
	Tel	+41-41-511-3280
		Address record changed: 2021-08-08

Basic data	Employees	n. a.

		* Document for »About Section«: mk2 Biotechnologies GmbH. (7/29/21). "Press Release: mk2 Biotechnologies Receives a Multi-Million Sum in Seed Funding".

		Record changed: 2024-04-04

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for Occident (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)